Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in manufacturing of pharmaceuticals products.
Emcure Pharmaceuticals Limited, is an unlisted public company incorporated on 16 April, 1981. It is classified as a public limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 250.00 cr and the total paid-up capital is INR 189.10 cr.
Read more
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Mukund Keshao Gurjar
Shareholder
|
00026843 | 24 years |
Whole-time Director | Sunil Rajanikant Mehta
Shareholder
|
00118469 | 12 years |
Managing Director | Satish Ramanlal Mehta
Shareholder
|
00118691 | 44 years |
CEO | Satish Ramanlal Mehta | <HIDDEN> | 5 years |
Director | Berjis Minoo Desai
Shareholder
|
00153675 | 28 years |
Director | Shailesh Kripalu Ayyangar | 00268076 | 4 years |
Whole-time Director | Samit Satish Mehta
Shareholder
|
00332562 | 3 years |
Director | Palamadai Sundararajan Jayakumar | 01173236 | 5 years |
Director | Vidya Rajiv Yeravdekar | 02183179 | 4 years |
Whole-time Director | Namita Vikas Thapar
Shareholder
|
05318899 | 11 years |
Director | Samonnoi Sajani Banerjee | 06874206 | 7 years |
Director | Vijay Keshav Gokhale | 09134089 | 4 years |
Kmp | Chetan Rajendra Sharma | <HIDDEN> | 2 years |
CFO | Tajuddin Sabir Shaikh | <HIDDEN> | 4 years |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2023 available in Tofler Pro
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Trustee Services Limited
No. of Loans: 9
Total Amount : 1,068.0 cr
Axis Bank Limited
No. of Loans: 13
Total Amount : 533.5 cr
Tata Capital Financial Services Limited
No. of Loans: 3
Total Amount : 170.0 cr
Bank of Baroda
No. of Loans: 1
Total Amount : 44.0 cr
HDFC Bank Limited
No. of Loans: 7
Total Amount : 2.6 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Emcure Pharma Peru S.A.C | Peru | - | - |
Emcure Pharma Mexico S.A. DE C.V. | Mexico | - | - |
Marcan Pharmaceuticals Inc | Canada | - | - |
Emcure Pharmaceuticals Pty Ltd | Australia | - | - |
Heritage Pharma Labs Inc. | United States | - | - |
Tillomed Pharma GmbH | Germany | - | - |
Tillomed Laboratories Ltd | United Kingdom | - | - |
Laboratorios Tillomed Spain SLU | Spain | - | - |
Tillomed Italia SRL | Italy | - | - |
Emcure NZ Limited | New Zealand | - | - |
GENNOVA BIOPHARMACEUTICALS LIMITED | Maharashtra | 2001 | ₹ 5.5 Cr |
Heritage Pharmaceuticals Inc. | United States | - | - |
Tillomed France SAS | France | - | - |
Hacco Pharma Inc | United States | - | - |
Tillomed Laboratories B.V. | Netherlands | - | - |
AVET LIFESCIENCES PRIVATE LIMITED | Maharashtra | 2020 | ₹ 15.4 Cr |
Emcure Pharma Chile SpA | Chile | - | - |
Lazor Pharmaceuticals Ltd. | Kenya | - | - |
ZUVENTUS HEALTHCARE LIMITED | Maharashtra | 2002 | ₹ 20.1 Cr |
Emcure Nigeria Limited | Nigeria | - | - |
Emcure Pharmaceuticals Mena FZ LLC | United Arab Emirates | - | - |
Emcure Pharmaceuticals South Africa (Pty) Limited | South Africa | - | - |
Emcure Brasil farmaceutica Ltda | Brazil | - | - |
Heritage Pharma Holdings Inc. | United States | - | - |
Emcure Pharma UK Ltd | United Kingdom | - | - |
Emcure Pharma Philippines Inc. | Philippines | - | - |
Tillomed d.o.o. | Croatia | - | - |
Emcure Pharma Philippines Inc | Philippines | - | - |
Read more
The incorporation date of EMCURE PHARMACEUTICALS LIMITED is 16 April, 1981
The authorized share capital of EMCURE PHARMACEUTICALS LIMITED is INR ₹ 250.0 Cr.
The paid-up capital of EMCURE PHARMACEUTICALS LIMITED is INR ₹ 189.1 Cr.
The registered address of EMCURE PHARMACEUTICALS LIMITED is Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C. Infotech Park (Hinjawadi) Pune City Pune Maharashtra - 411057
The CIN number of EMCURE PHARMACEUTICALS LIMITED is U24231PN1981PLC024251.